RFAs: Next Generation Research Grant in Mal de D?barquement Syndrome

Deadline: 08-Oct-26

The Next Generation Research Grant in Mal de Débarquement Syndrome (MdDS) provides up to $150,000 over two years to early career clinician-investigators and research scientists studying the causes, diagnosis, prevention, or treatment of MdDS. The grant supports basic, preclinical, clinical, and translational research and welcomes projects with potential applications to other neurological disorders. What Is the Next Generation Research Grant in MdDS? The Next Generation Research Grant in Mal de Débarquement Syndrome (MdDS) supports early career researchers conducting innovative research to improve understanding, diagnosis, prevention, and treatment of MdDS. The program follows the Cure One, Cure Many research philosophy, which recognizes that discoveries in one neurological condition can potentially lead to advances in other diseases. Research proposals may focus specifically on MdDS while also demonstrating broader relevance to neurological health. What Is Mal de Débarquement Syndrome? Mal de Débarquement Syndrome (MdDS) is a neurological disorder characterized by a persistent sensation of movement, such as rocking, swaying or bobbing, that commonly occurs after exposure to passive motion such as traveling by boat. Research supported through this grant may help improve understanding of: MdDS mechanisms. Diagnosis and disease identification. Prevention strategies. Treatment approaches. Neurological and sensory processes associated with MdDS. Potential connections between MdDS and other neurological conditions. Grant Funding The program provides $75,000 per year for two years, for a maximum total award of $150,000. The annual funding is divided as follows: $65,000 per year for salary support, including fringe benefits. $10,000 per year for research-related expenses.

Total funding: $150,000 over two years.

Indirect costs are not supported. All grant funds must be used directly for the proposed research project. Applicants may supplement the award with other funding as a Principal Investigator, provided the additional support does not cause total direct-cost support to exceed $75,000 annually. What Research Does the Grant Support? The grant welcomes a broad range of scientific approaches related to MdDS. Priority is given to innovative proposals that could advance the understanding, diagnosis, prevention or treatment of MdDS. Projects with translational potential or relevance to multiple neurological diseases are particularly encouraged. Who Is Eligible? The grant is intended for early career clinician-investigators and research scientists.

Applicants must:

Hold an MD, PhD, or equivalent terminal-level clinical or research degree. Have completed their clinical residency or terminal degree no later than six years before the award start date. For the 2027 award, the relevant completion year is 2021. Be affiliated with an accredited institution in the United States or internationally. Conduct research relevant to MdDS. There is no citizenship requirement. The program welcomes applicants from diverse scientific disciplines and backgrounds. Who Can Conduct the Research? The program is not limited to neurologists. Researchers from multiple fields may be competitive if their research directly addresses MdDS.

Relevant disciplines include:

Neurology. Neurotology. Otolaryngology. Neuroscience. Audiology. Physical therapy. Other relevant clinical and biomedical research fields. This interdisciplinary approach allows researchers to investigate MdDS from neurological, sensory, clinical and rehabilitation perspectives. Why It Matters MdDS can be difficult to understand, diagnose and treat, creating an important need for innovative research. The grant provides early career investigators with resources to establish independent research programs while investigating an under-studied neurological condition. The Cure One, Cure Many approach also encourages researchers to consider whether discoveries in MdDS could contribute to broader neurological research. Describing methods without explaining expected outcomes. Ignoring the potential translational significance of the research. Including indirect costs in the requested budget. Exceeding the permitted annual direct-cost support. Failing to explain how the research could contribute to understanding or treating MdDS. Frequently Asked Questions How much funding does the MdDS Next Generation Research Grant provide? The grant provides $75,000 per year for two years, totaling $150,000. What can the annual funding be used for? Up to $65,000 annually is designated for salary support, including fringe benefits, while $10,000 annually is available for research-related expenses. Who can apply for the grant? Eligible applicants are clinician-investigators or research scientists holding an MD, PhD or equivalent terminal-level degree who meet the early career requirements and are affiliated with an accredited US or international institution. What is the early career eligibility requirement? Applicants must have completed their clinical residency or terminal degree no later than six years before the award start date. For the 2027 award, the relevant completion year is 2021. Can researchers outside the United States apply? Yes. The program accepts applicants at accredited institutions in the United States and internationally, and there is no citizenship requirement. Does the research have to be clinical? No. The grant supports basic, preclinical, clinical and translational research related to MdDS. Can the research benefit other neurological diseases? Yes. Projects with potential cross-disease relevance and translational potential are particularly encouraged under the Cure One, Cure Many philosophy. Conclusion The Next Generation Research Grant in Mal de Débarquement Syndrome offers substantial support for early career researchers seeking to advance MdDS research. With up to $150,000 over two years, the program provides funding for salary and research expen